Activin A

Activin A

Activin A Product List

Species
  • Human(8)
Tag
  • Tag Free(7)
  • His Tag(1)
Host
  • CHO(4)
  • E. coli(2)
  • HEK293(2)
Conjugate
  • Unconjugated(8)
Grade
  • PG (pre-GMP)(3)
  • RUO(3)
  • GMP(2)
Low Endotoxin
  • No(8)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
Activin A
GMP Human Activin A / INHBA Protein
Human
CHO
SDS-PAGE
CELL BASE

$605.00

50ug
Activin A
GMP Human Activin A / INHBA Protein
Human
CHO
SDS-PAGE
CELL BASE

$5090.00

500ug
Activin A
Human Activin A / INHBA Protein, Tag Free
Human
HEK293
SDS-PAGE
ELISASPRCELL BASE

$300.00

25ug
Activin A
Human Latent Activin A / INHBA Protein, His Tag
Human
HEK293
SDS-PAGE
ELISASPRCELL BASE

$485.00

100ug
Activin A
Human Activin A / INHBA Protein (E. coli), premium grade
Human
E. coli
SDS-PAGE
ELISACELL BASE

$275.00

20ug
Activin A
Human Activin A / INHBA Superior Active Mutant Protein, premium grade
Human
E. coli
HPLCSDS-PAGE
CELL BASE

$330.00

20ug
Activin A
Human Activin A / INHBA Protein, premium grade
Human
CHO
SDS-PAGE
ELISACELL BASE

$275.00

20ug
Activin A
Human Activin A / INHBA Protein, Research Grade
Human
CHO
SDS-PAGE
ELISACELL BASE

$180.00

20ug
You Have Viewed 1-8 Of 8 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
BLU-782BLU-782; IPN-60130Phase 2 ClinicalBlueprint Medicines Corp, Ipsen SA
Myositis Ossificans
Details
ZilurgisertibINCB-000928; INCB-00928Phase 2 ClinicalIncyte Corp
Polycythemia Vera; Renal Insufficiency; Anemia; Myelodysplastic Syndromes; Ossification, Heterotopic; Multiple Myeloma; Primary Myelofibrosis; Myositis Ossificans; Thrombocythemia, Essential
Details
KER-047KER-047; TRND482477Phase 1 ClinicalNational Center For Advancing Translational Sciences
Anemia, Iron-Deficiency; Myositis Ossificans
Details
ItacnosertibTP-0184Phase 1 ClinicalTolero Pharmaceuticals Inc, Sumitomo Dainippon
Solid tumours; Anemia
Details
BCX-9250BCX-9250Phase 1 ClinicalBiocryst Pharmaceuticals Inc
Myositis Ossificans
Details
HS135HS-135Phase 1 Clinical35Pharma Inc
Hypertension, Pulmonary; Heart Failure, Diastolic; Pulmonary Arterial Hypertension
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Momelotinib DihydrochlorideCYT-387; GS-0387; GSK-3070785ApprovedGilead Sciences Inc, Cytopia Pty LtdOjjaara, OmjjaraUnited StatesPrimary Myelofibrosis; AnemiaGlaxosmithkline Llc, Glaxosmithkline Plc2023-09-15
Polycythemia Vera; Anemia; Myelodysplastic Syndromes; Neoplasms; Myeloproliferative Disorders; Pancreatic Intraductal Neoplasms; Primary Myelofibrosis; Carcinoma, Pancreatic Ductal; Splenomegaly; Thrombocythemia, Essential; Carcinoma, Non-Small-Cell Lung
Details
Customer Reviews